Metropolis Healthcare Complete Financial Statements
METROPOLIS • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Metropolis Healthcare (METROPOLIS).
Downloads include all available records across all periods.
For market performance, see the
METROPOLIS stock price today
.
Profitability Ratios
Net Profit Margin
12.33%
2025 data
EBITDA Margin
25.35%
2025 data
Operating Margin
25.00%
2025 data
Return on Assets
2.84%
2025 data
Return on Equity
3.97%
2025 data
Balance Sheet Ratios
Current Ratio
1.45
2025 data
Debt to Equity
1.40
2025 data
Equity Ratio
71.51%
2025 data
Asset Turnover
0.23
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+21.8%
Year-over-Year
Net Profit Growth
+12.8%
Year-over-Year
EBITDA Growth
+17.2%
Year-over-Year
Expense Growth
+23.5%
Year-over-Year
Assets Growth
+20.1%
Year-over-Year
Equity Growth
+21.5%
Year-over-Year
Liabilities Growth
+20.1%
Year-over-Year
Operating Cash Flow Growth
-0.4%
Year-over-Year
Investing Cash Flow Growth
-123.6%
Year-over-Year
Financing Cash Flow Growth
+51.9%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 430 | 352 | 394 | 353 | 334 | 316 | 325 | 310 | 284 | 280 | 293 | 305 | 312 | 283 | 292 | 308 | 294 | 346 | 296 | 291 | 210 | 146 | 279 | 225 | 203 | 205 | 225 | 198 | 178 | 193 |
| Expenses | 321 | 283 | 296 | 260 | 251 | 235 | 251 | 234 | 212 | 214 | 226 | 221 | 231 | 211 | 215 | 212 | 195 | 224 | 218 | 198 | 173 | 131 | 188 | 161 | 145 | 156 | 159 | 146 | 132 | 142 |
| EBITDA | 109 | 69 | 97 | 93 | 83 | 81 | 75 | 76 | 72 | 66 | 67 | 83 | 81 | 72 | 77 | 96 | 99 | 122 | 78 | 94 | 37 | 15 | 90 | 64 | 58 | 49 | 66 | 53 | 46 | 51 |
| Operating Profit Margin % | 25.00% | 18.00% | 23.00% | 26.00% | 24.00% | 25.00% | 22.00% | 24.00% | 25.00% | 23.00% | 22.00% | 26.00% | 24.00% | 24.00% | 25.00% | 30.00% | 33.00% | 31.00% | 26.00% | 32.00% | 16.00% | 8.00% | 32.00% | 28.00% | 28.00% | 24.00% | 29.00% | 25.00% | 25.00% | 26.00% |
| Depreciation | 32 | 29 | 31 | 27 | 26 | 26 | 28 | 22 | 23 | 21 | 25 | 22 | 18 | 21 | 23 | 15 | 14 | 13 | 17 | 11 | 11 | 10 | 11 | 9 | 5 | 8 | 11 | 5 | 5 | 5 |
| Interest | 6 | 5 | 5 | 5 | 6 | 5 | 5 | 6 | 6 | 6 | 5 | 7 | 6 | 8 | 6 | 3 | 3 | 6 | 5 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 0 | 0 |
| Profit Before Tax | 71 | 36 | 61 | 61 | 51 | 51 | 42 | 48 | 42 | 39 | 37 | 55 | 57 | 43 | 48 | 78 | 82 | 103 | 56 | 81 | 23 | 4 | 78 | 53 | 52 | 39 | 53 | 48 | 42 | 46 |
| Tax | 18 | 7 | 16 | 15 | 14 | 13 | 11 | 13 | 8 | 10 | 10 | 14 | 16 | 9 | 12 | 19 | 20 | 28 | 15 | 21 | 8 | 1 | 19 | 10 | 17 | 12 | 11 | 18 | 14 | 14 |
| Net Profit | 53 | 29 | 45 | 47 | 37 | 38 | 32 | 36 | 34 | 29 | 27 | 41 | 40 | 34 | 36 | 58 | 61 | 75 | 41 | 61 | 16 | 3 | 59 | 43 | 35 | 27 | 42 | 30 | 27 | 31 |
| Earnings Per Share (₹) | 10.17 | 5.69 | 8.70 | 9.08 | 7.11 | 7.41 | 6.12 | 6.92 | 6.51 | 5.62 | 5.30 | 7.88 | 7.81 | 6.53 | 6.99 | 11.39 | 12.05 | 14.65 | 8.02 | 11.88 | 3.09 | 0.57 | 11.50 | 8.57 | 6.87 | 5.34 | 8.38 | 6.14 | 4.83 | 6.26 |
Related Pages for Metropolis Healthcare
Additional stock information and data for METROPOLIS
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Total Assets | 1,867 | 1,555 | 1,502 | 1,530 | 1,004 | 752 | 553 | 530 |
| Current Assets | 346 | 316 | 303 | 393 | 609 | 397 | 305 | 300 |
| Fixed Assets | 1,447 | 1,177 | 1,121 | 1,059 | 343 | 296 | 213 | 207 |
| Capital Work in Progress | 0 | 0 | 20 | 6 | 0 | 3 | 6 | 0 |
| Investments | 71 | 55 | 15 | 16 | 10 | 14 | 33 | 102 |
| Other Assets | 349 | 323 | 347 | 450 | 651 | 439 | 301 | 221 |
| LIABILITIES | ||||||||
| Total Liabilities | 1,867 | 1,555 | 1,502 | 1,530 | 1,004 | 752 | 553 | 530 |
| Current Liabilities | 238 | 210 | 246 | 341 | 92 | 58 | 8 | 11 |
| Non-Current Liabilities | ||||||||
| SHAREHOLDERS' EQUITY | ||||||||
| Total Equity | 1,335 | 1,099 | 991 | 888 | 708 | 525 | 420 | 429 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | 1,313 | 1,086 | 978 | 876 | 696 | 513 | 409 | 405 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 263 | 264 | 247 | 253 | 249 | 215 | 90 | 104 | 102 | 91 | 70 |
| Investing Activities | -199 | -89 | 48 | -736 | 63 | -104 | 36 | 1 | -86 | 96 | -56 |
| Financing Activities | -87 | -181 | -292 | 163 | -33 | -55 | -118 | -87 | -17 | -174 | -10 |
| Net Cash Flow | -23 | -6 | 3 | -321 | 279 | 56 | 8 | 18 | -1 | 14 | 4 |